Written answers

Thursday, 24 October 2024

Department of Health

Medicinal Products

Photo of Michael MoynihanMichael Moynihan (Cork North West, Fianna Fail)
Link to this: Individually | In context

322. To ask the Minister for Health if a person in County Cork (details supplied) can continue to be reimbursed for the same medication under the GMS rather than changing to generic medication; and if he will make a statement on the matter. [43616/24]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context

The Health (Pricing and Supply of Medical Goods) Act 2013 permits community pharmacists to dispense generic medicines where a brand name medicine has been prescribed, provided they have been designated as interchangeable by the Health Products Regulatory Authority (HPRA).

Generic medicines must meet the same standards of quality and safety and have the same effect as the original medicine. All generic medicines on the Irish market are required to be properly licensed and meet the requirements of the HPRA.

Reference pricing means a single reimbursement price, or reference price, for a group of interchangeable medicines. This is the maximum price that the HSE will pay community pharmacies for all medicines in this group, regardless of the price of the individual medicine.

Section 13 (1) of the 2013 Act allows a prescriber to indicate on a prescription that a branded medicine should, for clinical reasons, not be substituted.

Therefore, if a patient wishes to remain on a particular branded medicine, they should discuss this with their clinician in the first instance who may, for clinical reasons, write ‘do not substitute’ on the prescription. If the clinician decides to write ‘do not substitute’, then the patient will not have to pay the difference between the reference price and the branded product price.

Comments

No comments

Log in or join to post a public comment.